Novacyt (NCYT) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free NCYT Stock Alerts GBX 69.60 +2.50 (+3.73%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLong Term Incentive Planactusnews.com - April 23 at 8:50 AMDHSC Claim update - Pre-Trial Reviewactusnews.com - April 19 at 3:23 AMAstraZeneca increases 2024 dividend by 7%lse.co.uk - April 13 at 12:43 AMDirectorate Changes and FY 23 results updateactusnews.com - April 11 at 7:23 AMUpdate on Taiwanese divestmentactusnews.com - February 6 at 10:00 AMNovacyt SA NYZmorningstar.com - January 30 at 10:47 PMTrading updateactusnews.com - January 25 at 4:36 AMReminder to shareholders re. AGM votingactusnews.com - September 30 at 3:39 PMCancellation of trading of Yourgene Sharesactusnews.com - September 11 at 3:45 AMNotice of rescheduled AGMactusnews.com - August 29 at 4:46 AMYourgene jumps 143% on Novacyt £16.7m knock-out bidproactiveinvestors.com - July 3 at 7:52 AMChipotle Mexica Share Chatlse.co.uk - June 24 at 3:31 PMNordtelekom Nyr Share Chatlse.co.uk - June 14 at 7:28 AMCalipso Oradea Share Chatlse.co.uk - June 12 at 6:22 PMPublication of Annual Report and AGM votingactusnews.com - May 26 at 11:09 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listedfinance.yahoo.com - January 30 at 9:58 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading Updatefinance.yahoo.com - January 26 at 7:51 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Changefinance.yahoo.com - December 7 at 3:45 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislationfinance.yahoo.com - December 6 at 4:34 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate Changefinance.yahoo.com - November 10 at 4:02 AMNovacyt gains UK approval for its multiplex PCR test for detection of winter virusesproactiveinvestors.com - October 26 at 9:18 AMNovacyt approved for COVID and winter viruses PCR testproactiveinvestors.com - October 26 at 9:18 AMYour three-minute digest - The Timesthetimes.co.uk - October 10 at 8:34 AMNovacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK - Marketscreener.commarketscreener.com - October 10 at 1:21 AMNovacyt subject to legal claim after 'troubling' Covid test results - The Timesthetimes.co.uk - October 9 at 8:21 PMOutlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 6 at 2:05 PMNovacyt S.A. 2022 Q2 - Results - Earnings Call Presentation (OTCMKTS:NVYTF) - Seeking Alphaseekingalpha.com - October 1 at 12:59 AMEARNINGS UPDATES: Volvere says interim performance... - Morningstarmorningstar.co.uk - September 29 at 1:48 PMNovacyt 1H Pretax Loss Narrowed Despite Major Revenue Decline - MarketWatchmarketwatch.com - September 29 at 8:48 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results - Business Wirebusinesswire.com - September 29 at 3:47 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Resultsfinance.yahoo.com - September 29 at 3:47 AMRapid Plasma Reagin Test Market to observe USD 46.28 Mn incremental growth -- Driven by increasing incidence of syphilis - PR Newswireprnewswire.com - September 21 at 12:38 AMUK Gov't Sues COVID-19 Test Designer For £135M - Law360law360.com - August 31 at 3:48 AMGlobal Organ Transplant Diagnostics Market to 2031 - Featuring Abbott Laboratories, ARUP Laboratories, BAG Health Care and bioMerieux Among Others - Yahoo Financefinance.yahoo.com - August 12 at 1:53 AMOutlook on the Organ Transplant Diagnostics Global Market to 2031 - High Demand for Molecular Diagnostic Tests is Driving Growth - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 10 at 3:56 PMTRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim - Morningstarmorningstar.co.uk - August 6 at 3:17 AMNovacyt Launches New Covid-19 PCR Assays - MarketWatchmarketwatch.com - August 4 at 11:09 AMLaunch of Novacyt's first fully lyophilised PROmate® assays - Business Wirebusinesswire.com - August 4 at 11:09 AMTRADING UPDATES: Scottish American outperforms; Amte picks Dundee | Financial News - London South Eastlse.co.uk - July 28 at 3:25 PMNovacyt S.A. (“Novacyt”, the “Company” or the “Group”): Launch of Research-Use-Only Adenovirus F41 Assay - Business Wirebusinesswire.com - July 28 at 5:16 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Launch of Research-Use-Only Adenovirus F41 Assayfinance.yahoo.com - July 28 at 5:16 AMNovacyt : Results of Annual General Meeting - Marketscreener.commarketscreener.com - July 21 at 1:03 PMAIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise - Morningstarmorningstar.co.uk - July 15 at 7:17 PMNovacyt - Approval of exsig COVID-19 Direct test in the UK under CTDA legislation - Marketscreener.commarketscreener.com - July 15 at 2:17 PMAIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise | Financial News - London South Eastlse.co.uk - July 15 at 9:17 AMNovacyt's exsig receives UK approval | Financial News - London South Eastlse.co.uk - July 15 at 9:17 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of exsig™ COVID-19 Direct Test in the UK Under CTDA Legislation - Business Wirebusinesswire.com - July 15 at 9:17 AMNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Trading Update and Progress Against Strategy for H1 2022 - Yahoo Financefinance.yahoo.com - July 9 at 3:41 PMKenmare Resources climbs after positive broker note - Proactive Investors Australiaproactiveinvestors.com.au - July 7 at 5:47 PMAIM WINNERS & LOSERS: Novacyt revenue falls but Bidstack's jumps - Morningstarmorningstar.co.uk - July 7 at 8:47 AM Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. NCYT Media Mentions By Week NCYT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCYT News Sentiment▼0.000.58▲Average Medical News Sentiment NCYT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCYT Articles This Week▼00▲NCYT Articles Average Week Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Creo Medical Group News EKF Diagnostics News ANGLE News Arecor Therapeutics News Venture Life Group News Renalytix News e-therapeutics News Redx Pharma News C4X Discovery News Celadon Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:NCYT) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap Profits[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.